Filing
1st Quarter - Report
Lobbying activity
5
Issues related to drug pricing, pharmacies, provider status, biosimilars, cell and gene therapy, behavioral health, food is medicine, acute hospital care at home waiver; Issues related to provider reimbursement, Medicare and Medicaid, workforce shortages, pandemic preparedness, and product shortages.
Education on supply chain issues, drug shortages, domestic manufacturing, medical device environmental issues; Issues related to the medical supply chain and transportation bottlenecks.
Issues related to tax reform and 2017 Tax Cuts and Jobs Act.
Issues related to tariffs, trade, and U.S. trade policy.
Issues related to tariffs, trade, and U.S. trade policy.